000 | 01521 a2200445 4500 | ||
---|---|---|---|
005 | 20250512060535.0 | ||
264 | 0 | _c19870521 | |
008 | 198705s 0 0 eng d | ||
022 | _a0301-5149 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aJust, M | |
245 | 0 | 0 |
_aEvaluation of a combined vaccine against measles-mumps-rubella produced on human diploid cells. _h[electronic resource] |
260 |
_bDevelopments in biological standardization _c1986 |
||
300 |
_a25-7 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntibodies, Viral _xbiosynthesis |
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 | _aChick Embryo |
650 | 0 | 4 | _aChild, Preschool |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 |
_aDrug Combinations _xadverse effects |
650 | 0 | 4 | _aFluorescent Antibody Technique |
650 | 0 | 4 | _aHemagglutination Inhibition Tests |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInfant |
650 | 0 | 4 |
_aMeasles Vaccine _xadverse effects |
650 | 0 | 4 |
_aMeasles virus _ximmunology |
650 | 0 | 4 | _aMeasles-Mumps-Rubella Vaccine |
650 | 0 | 4 |
_aMumps Vaccine _xadverse effects |
650 | 0 | 4 |
_aMumps virus _ximmunology |
650 | 0 | 4 |
_aRubella Vaccine _xadverse effects |
650 | 0 | 4 |
_aRubella virus _ximmunology |
650 | 0 | 4 | _aVaccination |
700 | 1 | _aBerger, R | |
700 | 1 | _aGlück, R | |
700 | 1 | _aWegmann, A | |
773 | 0 |
_tDevelopments in biological standardization _gvol. 65 _gp. 25-7 |
|
999 |
_c3555119 _d3555119 |